$3.35T
Total marketcap
$142.89B
Total volume
BTC 60.75%     ETH 8.56%
Dominance

Cardiac Biotech CBSC Stock

0.03 USD {{ price }} 0.000000% {{change_pct}}%
Market Cap
5.49M USD
LOW - HIGH [24H]
0.03 - 0.04 USD
VOLUME [24H]
30K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Cardiac Biotech Price Chart

Cardiac Biotech CBSC Financial and Trading Overview

Cardiac Biotech stock price 0.03 USD
Previous Close 0.17 USD
Open 0.17 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 0.17 - 0.17 USD
52 Week Range 0.12 - 0.3 USD
Volume 27.8K USD
Avg. Volume 28.32K USD
Market Cap 20.92M USD
Beta (5Y Monthly) 0.614084
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

CBSC Valuation Measures

Enterprise Value 9.94M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 415.23944
Price/Book (mrq) N/A
Enterprise Value/Revenue 197.279
Enterprise Value/EBITDA -13.872

Trading Information

Cardiac Biotech Stock Price History

Beta (5Y Monthly) 0.614084
52-Week Change 16.43%
S&P500 52-Week Change 20.43%
52 Week High 0.3 USD
52 Week Low 0.12 USD
50-Day Moving Average 0.15 USD
200-Day Moving Average 0.17 USD

CBSC Share Statistics

Avg. Volume (3 month) 28.32K USD
Avg. Daily Volume (10-Days) 44.27K USD
Shares Outstanding 123.03M
Float N/A
Short Ratio N/A
% Held by Insiders N/A
% Held by Institutions N/A
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2018
Most Recent Quarter (mrq) March 31, 2018
Next Fiscal Year End March 31, 2019

Profitability

Profit Margin 0%
Operating Margin (ttm) -1485.99%
Gross Margin 54.34%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 50.37K USD
Revenue Per Share (ttm) 0.001 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) 23.49K USD
EBITDA -716355 USD
Net Income Avi to Common (ttm) -640547 USD
Diluted EPS (ttm) -0.02
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 4.67K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.029
Book Value Per Share (mrq) -0.024

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Cardiac Biotech

Country United States
State NV
City Las Vegas
Address 10845 Griffith Peak Drive
ZIP 89135
Phone 888-225-0870
Website https://cbscientificinc.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 5

CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company is based in Las Vegas, Nevada.

Q&A For Cardiac Biotech Stock

What is a current CBSC stock price?

Cardiac Biotech CBSC stock price today per share is 0.03 USD.

How to purchase Cardiac Biotech stock?

You can buy CBSC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cardiac Biotech?

The stock symbol or ticker of Cardiac Biotech is CBSC.

Which industry does the Cardiac Biotech company belong to?

The Cardiac Biotech industry is Medical Instruments & Supplies.

How many shares does Cardiac Biotech have in circulation?

The max supply of Cardiac Biotech shares is 161.37M.

What is Cardiac Biotech Price to Earnings Ratio (PE Ratio)?

Cardiac Biotech PE Ratio is now.

What was Cardiac Biotech earnings per share over the trailing 12 months (TTM)?

Cardiac Biotech EPS is 0 USD over the trailing 12 months.

Which sector does the Cardiac Biotech company belong to?

The Cardiac Biotech sector is Healthcare.